IHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Aix-Marseille University, Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), MEPHI, 27 Boulevard Jean Moulin, 13005 Marseille, France.
Viruses. 2021 Apr 28;13(5):775. doi: 10.3390/v13050775.
It has now been over a year since SARS-CoV-2 first emerged in China, in December 2019, and it has spread rapidly around the world. Some variants are currently considered of great concern. We aimed to analyze the numbers of SARS-CoV-2 genome sequences obtained in different countries worldwide until January 2021. On 28 January 2021, we downloaded the deposited genome sequence origin from the GISAID database, and from the "Our world in data" website we downloaded numbers of SARS-CoV-2-diagnosed cases, numbers of SARS-CoV-2-associated deaths, population size, life expectancy, gross domestic product (GDP) per capita, and human development index per country. Files were merged and data were analyzed using Microsoft Excel software. A total of 450,968 SARS-CoV-2 genomes originating from 135 countries on the 5 continents were available. When considering the 19 countries for which the number of genomes per 100 deaths was >100, six were in Europe, while eight were in Asia, three were in Oceania and two were in Africa. Six (30%) of these countries are beyond rank 75, regarding the human development index and four (20%) are beyond rank 80 regarding GDP per capita. Moreover, the comparisons of the number of genomes sequenced per 100 deaths to the human development index by country show that some Western European countries have released similar or lower numbers of genomes than many African or Asian countries with a lower human development index. Previous data highlight great discrepancies between the numbers of available SARS-CoV-2 genomes per 100 cases and deaths and the ranking of countries regarding wealth and development.
自 2019 年 12 月在中国首次出现 SARS-CoV-2 以来，已经过去了一年多，它已迅速在全球传播。目前一些变体被认为非常令人担忧。我们旨在分析截至 2021 年 1 月在全球不同国家获得的 SARS-CoV-2 基因组序列数量。2021 年 1 月 28 日，我们从 GISAID 数据库下载了已保存的基因组序列来源，从“我们的世界数据”网站下载了 SARS-CoV-2 确诊病例数、SARS-CoV-2 相关死亡人数、人口规模、预期寿命、人均国内生产总值（GDP）和每个国家的人类发展指数。合并文件并使用 Microsoft Excel 软件分析数据。共有来自 5 大洲 135 个国家的 450,968 个 SARS-CoV-2 基因组。在考虑 19 个基因组数量与每 100 例死亡人数之比超过 100 的国家时，其中 6 个位于欧洲，8 个位于亚洲，3 个位于大洋洲，2 个位于非洲。这 6 个国家（30%）在人类发展指数方面排名低于 75 位，4 个国家（20%）在人均 GDP 方面排名低于 80 位。此外，对各国每 100 例死亡测序的基因组数量与人类发展指数进行比较表明，一些西欧国家发布的基因组数量与人类发展指数较低的许多非洲或亚洲国家相似或更低。以前的数据突出了可用的 SARS-CoV-2 基因组数量与每 100 例病例和死亡人数以及国家财富和发展排名之间存在巨大差异。
